You need cookies enabled

HEFCE closed at the end of March 2018. The information on this website is historical and is no longer maintained.

Many of HEFCE's functions will be continued by the Office for Students, the new regulator of higher education in England, and Research England, the new council within UK Research and Innovation.

The HEFCE domain - - will continue to function until September 2018. At this point we will close the site entirely and all its information will only be available from the National Web Archive.


You need cookies enabled

Project summary

Kings College London will establish an Advanced Therapies Centre, bringing together expertise, manufacturing capability and experimental medicine research facilities for cell and gene therapy. 

These therapies offer enormous promise for severe, intractable diseases, but their development is limited by access to clinical-grade manufacturing infrastructure and early-phase trials capabilities.

The Centre will be open to academic and industry partners across London and the UK, and support the planned Cell and Gene Therapy Catapult large-scale manufacturing facility. 

The Centre will create a unique addition to the UK’s biomedical research and development capability. It will trigger a substantial investment in the UK by pharmaceutical companies, creating high value jobs, scientific advances, and ground-breaking improvements in healthcare.

Page last updated 5 July 2017